SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Medical Oncology Referral — Audre Lorde — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Audre Lorde |
|---|
| Date of birth | 1934-02-18 |
|---|
| Identifiers | MRN HR-ML016-SYN-TD; SSN (made up) 000-16-2937 |
|---|
| Document date | 1979-03-09 |
|---|
| Author | Naomi Fairweather, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Woman of 45, five and a half months after right total mastectomy for stage IA hormone receptor-positive, HER2-negative breast cancer, on tamoxifen since one month after surgery and now moving her survivorship care to primary care at this center. Please review the adjuvant endocrine plan and advise on hot flashes, surveillance, and genetic assessment, so that we can share her follow-up. [S]
Urgency: Routine, within four weeks. [S]
Questions for the consultant:
- Is tamoxifen alone the right adjuvant endocrine therapy for her, or is ovarian function suppression or an aromatase inhibitor indicated, and for how long?
- How should her hot flashes be managed safely alongside tamoxifen?
- What surveillance does she need, and are any blood tests, tumor markers, or scans indicated?
- Should she have germline genetic testing now, and would a result change her care?
- What should primary care monitor on tamoxifen, and how should we share her follow-up?
History of Present Illness
Right breast lump found at self-examination last September. Diagnostic mammogram and ultrasound: 1.6 cm mass, BI-RADS 5, normal axillary nodes. Core biopsy: invasive ductal carcinoma, grade 2, ER 90 percent, PR 60 percent, HER2 1+, Ki-67 12 percent. Right total mastectomy with flat closure and sentinel node biopsy: 1.6 cm, margins clear, 0 of 2 nodes, pT1c pN0(sn), stage IA; recurrence score 14. No chemotherapy or radiation. Tamoxifen 20 mg daily since late October. Premenopausal, with regular cycles. Mild hot flashes three or four times a day. No other medicines; no known allergy. PHQ-9 4, GAD-7 3. Germline testing was not offered at diagnosis. She chose not to have reconstruction and does not wish to wear an external prosthesis; she asks that this be respected and not revisited unless she raises it. She wants complete information and makes her own decisions [S]
- Moving her breast cancer survivorship care to primary care, with the oncology team kept informed; mild hot flashes on tamoxifen. [S]
- Wants complete information and to make her own decisions. She chose a flat closure without reconstruction and does not wish to wear an external prosthesis; she asks that this not be raised again unless she raises it. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Audre Lorde was born Audrey Geraldine Lorde on February 18, 1934, in New York City; her parents were immigrants from Grenada. [D]
- Lorde was a poet, essayist, and novelist. In her poetry and prose she wrote about matters important to her as a woman of color, as a lesbian, as a mother, and as a feminist; a reference biography describes her as an African American lesbian feminist and poet. [D]
- In 1977 a doctor found a tumor in Lorde's breast that, after about three weeks of uncertainty, proved benign. In a talk given that year to the Modern Language Association she said: "Your silence will not protect you." [D]
- On Labor Day 1978, during a routine self-examination, Lorde found a lump in her right breast; a diagnosis of malignancy and a mastectomy followed. She described the experience in The Cancer Journals. [D]
- After her mastectomy Lorde chose never to hide the fact of her missing breast. She refused to wear the "wad of lambswool pressed into a pale pink breast-shaped pad" pushed on her by nurses and medical counselors, and she was repeatedly scolded for posing a threat to cancer patient "morale." [D]
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Tamoxifen 20 mg oral tablet, one tablet by mouth once daily, planned for at least five years | One tablet once daily | Oral route | 1978-10-27 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1931 breast cancer and mastectomy | active | confirmed |
C50.411 | S — Synthetic tumor details and treatment; the diagnosis and the mastectomy are documented (D), but no tumor details from her lifetime are used. |
| Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent) | active | confirmed |
Z17.0 | S — Synthetic receptor result; no receptor status from her lifetime is known. |
| Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesis | active | confirmed |
Z90.11 | S — Synthetic coding of the documented mastectomy; the decision about a prosthesis echoes her documented choice and is respected as her own. |
| Long-term use of tamoxifen as adjuvant endocrine therapy | active | confirmed |
Z79.810 | S — Synthetic treatment status. |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| 1977 | Breast tumor found by a doctor, benign after about three weeks of uncertainty | D (CLM-0003) |
| 1978 | Lump in the right breast found at self-examination on Labor Day, followed by a diagnosis of breast cancer and a mastectomy; she declined a breast prosthesis | D (CLM-0004, CLM-0005) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Occupation: poet and essayist; writes most days and gives readings [S]
- Never smoker; alcohol rarely; walks most days; cooks most meals at home with plenty of vegetables and whole grains [S]
- Lives with her partner and her two teenage children; independent [S]
- Supports: her family and a wide circle of writers and friends [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1979-03-09 | Body height | 168 | cm | S |
| 1979-03-09 | Body weight | 72 | kg | S |
| 1979-03-09 | Body mass index (BMI) [Ratio] | 25.5 | kg/m2 | S |
| 1979-03-09 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1979-03-09 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1979-03-09 | Heart rate | 74 | /min | S |
| 1979-03-09 | Respiratory rate | 14 | /min | S |
| 1979-03-09 | Body temperature | 36.7 | Cel | S |
| 1979-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1979-03-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | | | S |
| 1979-03-09 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | | | S |
Assessment
- Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1931 breast cancer and mastectomy: active, confirmed [S]
- Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent): active, confirmed [S]
- Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesis: active, confirmed [S]
- Long-term use of tamoxifen as adjuvant endocrine therapy: active, confirmed [S]
Plan of Treatment
- Tamoxifen 20 mg daily for at least five years, with questions at every visit about hot flashes, abnormal vaginal bleeding, and leg swelling or breathlessness, and a yearly gynecologic assessment. Guideline: Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update (2019); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026) [S]
- Lymphedema risk counseling and arm checks at every visit; bone health by calcium and vitamin D from diet and weight-bearing exercise; distress, depression, and anxiety screening at intervals. Guideline: American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 2016;66(1):43-73 (2016); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026) [S]
- Written survivorship care plan, at least 150 minutes of activity a week, alcohol at or below one drink a day, and her decisions about reconstruction and a prosthesis recorded and respected. Guideline: American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 2016;66(1):43-73 (2016); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026) [S]
- Referral to medical oncology, Beatriz Lozano, MD, ordered 1979-03-09 [S]